Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast ...

These receptors initiate two arms of the immune ... mast cells, macrophages, and dendritic cells. These cells leave the bloodstream and take up residence in tissues throughout the body, where ...

In addition, Midkine reprograms dendritic cells to change their function so that they promote tumor development. "In this research, we found that Midkine acts as a shield and accelerator at the ...

If you've ever noticed how memories from the same day seem connected while events from weeks apart feel separate, a new study ...

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer.

BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than ...

A new generation of cancer therapies has emerged over the past few decades, including checkpoint inhibitors and chimeric antigen receptor ... killer (NK) cells, macrophages and dendritic cells ...

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor ...

Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen ...